Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H31Br2NO5 |
InChIKeyHDESYCKIVOTMPG-UHFFFAOYSA-N |
CAS Registry2213926-11-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 May 2018 |